Skip to content

The Effect of the ERAS Programme on Clinical Recovery in Patients Undergoing Laparotomy for Benign Gynaecological Conditions

Investigation of the Effect of the Enhanced Recovery After Surgery (ERAS) Programme on the Quality of Recovery in Patients Undergoing Laparotomy for Benign Gynaecological Conditions

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260723010
Enrollment
80
Registered
2026-07-23
Start date
2024-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative recovery in women undergoing laparotomy for benign gynaecological conditions Enhanced Recovery After Surgery, Laparotomy, Gynecologic Surgical Procedures, Postoperative Care, Postoperative Nausea and Vomiting, Acute Pain, Length of Stay

Interventions

Participants received a structured Enhanced Recovery After Surgery programme throughout the preoperative, intraoperative, and postoperative periods. The programme included preoperative patient educati
Experimental Behavioral,Active Comparator Behavioral
Enhanced Recovery After Surgery programme,Standard perioperative care

Sponsors

No external monetary or material support was received for this study.
Lead Sponsor
No external monetary or material support was received for this study.
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for elective laparotomy for benign gynaecological conditions. 2. Patients undergoing total abdominal hysterectomy with or without additional benign gynaecological procedures. 3. Patients who provided written informed consent to participate in the study. 4. Patients who were able to understand and comply with the study procedures and postoperative assessments.

Exclusion criteria

Exclusion criteria: 1. Patients undergoing emergency surgery. 2. Patients undergoing surgery for suspected or confirmed gynaecological malignancy. 3. Patients undergoing minimally invasive surgery, including laparoscopic or vaginal procedures. 4. Patients with severe systemic disease or medical conditions that could significantly affect postoperative recovery. 5. Patients with cognitive impairment or communication difficulties that prevented understanding of the study procedures or completion of postoperative assessments. 6. Patients who declined to participate or withdrew their informed consent.

Design outcomes

Primary

MeasureTime frame
Postoperative pain intensity At 2, 6, 12, and 24 hours after surgery Visual Analogue Scale score

Secondary

MeasureTime frame
Length of hospital stay at hospital discharge Number of days from the date of surgery to hospital discharge

Countries

Turkey

Contacts

Public ContactBerkay Deyirmenci

Health Sciences University

bdeyirmenci@gmail.com905339613692

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026